The contract research organization (CRO) industry is poised to record significant proceeds through the ensuing years, due to a rise in research and development expenditure at the global level. The highest R&D expenses are registered in the biopharmaceutical and pharmaceutical industries.

To highlight, numerous pharma and biopharmaceutical companies have started outsourcing clinical trial services, boosting industry growth. In addition, several CRO companies are focusing on expansion strategies such as mergers, acquisitions, as well as product launch initiatives.

For instance, in December 2020, a leading provider of alternative investment products, Investcorp, announced the acquisition of Sanos Group, which is a leading provider of specialized clinical trial services to the worldwide biotechnology and pharmaceutical industry.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/3012

Similar initiatives are expected to drive the demand for contract research organization services through the forthcoming years. On this note, the contract research organization (CRO) market share is anticipated to surpass USD 74.2 billion by 2027, states the latest research by Global Market Insights, Inc.

This growth is due to an escalation in the outsourcing of research activities to academic institutions. Academic institutes are expected to depict a remarkable CAGR of 6.2% through the projected span. Several academic medical institutes have core IRB (Institutional Review Boards) that are responsible for supervising the moral manner of medical research. These boards also provide sites as well as large urban areas having a greater pool of medical participants.

The contract research organization (CRO) market is further driven by an increase in investments in research and development activities in the areas of gastroenterology & hepatology. The segment is set to record a value of USD 3 billion of the overall market share by 2027.

This revenue is attributed to the rising focus of various types of contract research organizations on clinical trial development in the sector of gastroenterology & hepatology. Increasing incidences of chronic hepatology disorders comprising cirrhosis and hepatitis-A at the global level are expected to augment the new drug development process for the treatment of these disorders, bolstering contract research organization (CRO) industry outlook through the forecasted period.

Request for customization @ https://www.decresearch.com/roc/3012

Speaking of which, there is a considerable rise in number of clinical trials as well as R&D initiatives, emergence of severe diseases, and a huge patient pool in Asia Pacific. In fact, the regional contract research organization market size is estimated to grow at a substantial CAGR of 9.1% between 2021 and 2027.

In addition, governments of numerous countries in the Asia Pacific are showing a keen interest in the provision of funding for drug discovery and associated research studies. Further, the region has also recorded a remarkable shift in biotechnology firms, which has been instrumental in impelling the growth of contract research organization (CRO) industry.

To add on, amid the COVID-19 pandemic, a spike in the number of SARS-CoV-2 cases has been responsible for attracting CROs for conducting trials to fast-track procedures and take advantage of the huge patient population, thereby propelling Asia Pacific CRO market growth through 2027.

In a nutshell, an increase in the expenditure on research and development activities and a rise in the number of drugs in numerous phases will spur contract research organization market size through the assessment period.

Partial Chapter of the Table of Content

Chapter 2   Executive Summary

2.1    Contract research organization industry 360° synopsis, 2016 - 2027

2.1.1    Business trends

2.1.2    Service type trends

2.1.3    Therapeutic area trends

2.1.4    End-use trends

2.1.5    Regional trends

Chapter 3   Contract Research Organization Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 - 2027

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Increasing R&D expenditure worldwide

3.3.1.2    Growing number of clinical trials in emerging countries

3.3.1.3    Growing outsourcing of R&D activities

3.3.1.4    Rising technological advancements

3.3.2    Industry pitfalls & challenges

3.3.2.1    Intellectual property rights issues

3.3.2.2    Stringent regulatory policies

3.4    Growth potential analysis

3.4.1    By service type

3.4.2    By therapeutic area

3.4.3    By end-use

3.5    COVID-19 impact analysis

3.6    Regulatory landscape

3.7    Porter's analysis

3.8    Competitive landscape, 2020

3.8.1    Company matrix analysis

3.9    PESTEL analysis

Browse complete Table of Contents (ToC) of this research report @ https://www.decresearch.com/toc/detail/contract-research-organization-cro-market